Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics. (Q33376498)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q47344831)
(Q39399978)
(Q42814411)
(Q5930658)
(Q100736896)
(Q87885218)
(Q87664147)
(Q89582275)
(Q114442097)
(Q87885216)
(P304) 4452-4458
(P407) (Q1860)
(P433) 28
(P478) 25
(P577) Tuesday, September 4, 2007
(P921) (Q42824440)
(Q422252)
(Q467635)
(P1433) (Q400292)
(P1476) "Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics" (language: en)
(P2093) Anna Sureda
Pedro García-Sánchez
Carlos Herrero
Xiangyang Liu
other details
description scientific article

External Links